Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 256–270 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5145 B3GALT6 Gene Sequencing for Ehlers-Danlos Syndrome, Progeroid Type 2 (NGS) Test This test identifies pathogenic variants in the B3GALT6 gene associated with Ehlers-Danlos Syndrome, progeroid type 2 (EDSP2).	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Biallelic pathogenic variants in the B3GALT6 gene"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist of bleeding disorder or anticoagulant use"] Indications ["Clinical suspicion of Ehlers-Danlos Syndrome, progeroid type 2 (EDSP2)"] Measurement technique Confirm with laboratory Codes LOINC: 57903-0 ICD-10: Q79.6 Clinical summary This test identifies pathogenic variants in the B3GALT6 gene associated with Ehlers-Danlos Syndrome, progeroid type 2 (EDSP2).
TEST-5739 B4GALNT1 Gene SPG26 Genetic Test This test evaluates the entire B4GALNT1 gene for pathogenic variants associated with Hereditary Spastic Paraplegia Type 26 (SPG26).	Peripheral whole blood (3–5 mL in EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants (SNVs, small indels, copy number variations) in the B4GALNT1 gene", "Full gene coverage (coding exons ± flanking intronic regions)"] Parameters [] Preparation [] Indications ["Patients with clinical spastic paraplegia", "Family history of SPG26", "Carrier testing"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: G11.4 Clinical summary This test evaluates the entire B4GALNT1 gene for pathogenic variants associated with Hereditary Spastic Paraplegia Type 26 (SPG26).
TEST-6341 B4GALT1 Gene Glycosylation Disorder Type 2D (CDG-IId) Genetic Test This genetic test analyzes the B4GALT1 gene to identify pathogenic variants associated with Congenital Disorder of Glycosylation Type IId (CDG-IId). It confirms or rules out the di...	Whole blood (EDTA), extracted genomic DNA, or FTA card dried blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["B4GALT1 gene sequence", "Copy Number Variants (CNVs) in B4GALT1"] Parameters [] Preparation ["No fasting required", "No medication changes required", "Mandatory genetic counselling session before sample collection", "Detailed three-generation family history required"] Indications ["Suspected Congenital Disorder of Glycosylation Type IId", "Biochemical testing suggesting CDG"] Measurement technique Confirm with laboratory Codes LOINC: 83886-6 ICD-10: E77.8 Clinical summary This genetic test analyzes the B4GALT1 gene to identify pathogenic variants associated with Congenital Disorder of Glycosylation Type IId (CDG-IId). It confirms or rules out the diagnosis in symptomatic individuals.
TEST-5185 B4GALT7 Gene Ehlers-Danlos Syndrome Progeroid Type 1 Genetic Test This genetic test identifies pathogenic variants in the B4GALT7 gene associated with Ehlers-Danlos syndrome progeroid type 1.	Whole Blood (EDTA, 2–5 mL) or FTA Card	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the B4GALT7 gene", "Point mutations", "Small insertions/deletions", "Large rearrangements"] Parameters [] Preparation ["No fasting required", "Inform clinical team of known bleeding disorder or INR > 3.0", "Genetic counseling session advised prior to testing"] Indications ["Suspected Ehlers-Danlos syndrome progeroid type 1", "Family history of connective tissue disorders", "Definitive diagnosis", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21665-7 ICD-10: Q79.6 Clinical summary This genetic test identifies pathogenic variants in the B4GALT7 gene associated with Ehlers-Danlos syndrome progeroid type 1.
TEST-3691 B9D2 Gene Meckel Syndrome Type 10 Next-Generation Sequencing (NGS) Genetic Test This test identifies pathogenic variants in the B9D2 gene associated with Meckel syndrome type 10.	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the B9D2 gene", "Copy Number Variations (CNV) in the B9D2 gene"] Parameters [] Preparation [] Indications ["Diagnosis of Meckel syndrome type 10", "Carrier screening for Meckel syndrome type 10", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 92822-6 ICD-10: Q61.9 Clinical summary This test identifies pathogenic variants in the B9D2 gene associated with Meckel syndrome type 10.
TEST-6267 BAAT Gene Hypercholanemia Genetic Test This test evaluates the BAAT gene for mutations associated with hypercholanemia, a rare bile acid metabolism disorder.	Whole Blood (Peripheral Blood)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BAAT gene pathogenic variants", "Bile acid metabolism pathway integrity"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "Informed consent required"] Indications ["Suspected hypercholanemia", "Family history of bile acid disorders", "Unexplained cholestasis", "Liver disease of unknown origin"] Measurement technique Confirm with laboratory Codes LOINC: 82342-1 ICD-10: E80.7 Clinical summary This test evaluates the BAAT gene for mutations associated with hypercholanemia, a rare bile acid metabolism disorder.
TEST-136 Bacterial Transcriptome Sequencing & Reference-Based Analysis Test This test evaluates the active gene expression profile of bacterial communities within a sample.	Whole blood (5 mL) or extracted genomic DNA	8 weeks	3,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Active bacterial genes", "Microbial pathogenesis", "Antibiotic resistance", "Host-microbe interactions"] Parameters [] Preparation ["No fasting required", "No special preparation required"] Indications ["Research into microbial pathogenesis", "Investigation of antibiotic resistance", "Study of host-microbe interactions", "Precision medicine for oncological patients", "Precision medicine for rheumatological patients"] Measurement technique Confirm with laboratory Codes LOINC: 88280-8 ICD-10: Z01.7 Clinical summary This test evaluates the active gene expression profile of bacterial communities within a sample.
TEST-4328 BAG3 Gene Dilated Cardiomyopathy (Type 1HH) Genetic Test This genetic test evaluates for pathogenic variants in the BAG3 gene associated with dilated cardiomyopathy type 1HH.	Whole Blood (peripheral), Extracted DNA, or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BAG3 gene", "Copy Number Variations (CNVs) in the BAG3 gene"] Parameters [] Preparation [] Indications ["Diagnosis confirmation of dilated cardiomyopathy type 1HH", "Familial risk assessment", "Guiding precision management"] Measurement technique Confirm with laboratory Codes LOINC: 91628-8 ICD-10: I42.0 Clinical summary This genetic test evaluates for pathogenic variants in the BAG3 gene associated with dilated cardiomyopathy type 1HH.
TEST-5266 BAG3 Gene Myopathy (Myofibrillar Myopathy Type 6) Genetic Test This genetic test detects mutations in the BAG3 gene associated with Myofibrillar Myopathy Type 6.	Peripheral whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the BAG3 gene", "Point mutations", "Small insertions/deletions", "Copy-number variations (CNVs)"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "99.9%"}] Preparation ["No fasting required", "No medication changes required unless directed by a doctor", "Pre-test genetic counselling session mandatory"] Indications ["Suspected diagnosis of BAG3-related myofibrillar myopathy", "Patients with clinical features consistent with myofibrillar myopathy", "Family members of individuals diagnosed with BAG3 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 48019-2 ICD-10: G71.09, Z13.71 Clinical summary This genetic test detects mutations in the BAG3 gene associated with Myofibrillar Myopathy Type 6.
TEST-1885 BAP1 Tumor Predisposition Syndrome Genetic Test This genetic test detects germline mutations in the BAP1 gene associated with an increased risk of multiple hereditary cancer syndromes.	Peripheral Whole Blood (also acceptable: dried DNA FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BAP1 gene mutations", "Germline genetic variants"] Parameters [] Preparation ["No specific fasting required.", "Inform your physician about any medications you are taking."] Indications ["Individuals with a personal or family history of uveal melanoma, malignant mesothelioma, cutaneous melanoma, or renal cell carcinoma.", "Individuals with a known familial BAP1 mutation."] Measurement technique Confirm with laboratory Codes LOINC: 97656-5 ICD-10: Z15.09 Clinical summary This genetic test detects germline mutations in the BAP1 gene associated with an increased risk of multiple hereditary cancer syndromes.
TEST-2151 BARD1 Gene Breast Cancer Susceptibility Genetic Test This genetic test evaluates for germline mutations within the BARD1 gene, a tumour suppressor associated with hereditary breast cancer susceptibility.	Whole Blood (Peripheral)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the BARD1 gene"] Parameters [] Preparation [] Indications ["Personal or family history of breast cancer", "Assessment of hereditary cancer susceptibility"] Measurement technique Confirm with laboratory Codes LOINC: 91156-2 ICD-10: Z15.01 Clinical summary This genetic test evaluates for germline mutations within the BARD1 gene, a tumour suppressor associated with hereditary breast cancer susceptibility.
TEST-3961 BBS10 Gene Bardet‑Biedl Syndrome Type 10 Genetic Test This genetic test identifies pathogenic variants within the BBS10 gene, which are associated with Bardet-Biedl syndrome type 10.	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BBS10 gene", "Copy number variants in the BBS10 gene"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected Bardet-Biedl syndrome type 10", "Family history of Bardet-Biedl syndrome", "Clinical features suggestive of ciliopathy"] Measurement technique Confirm with laboratory Codes LOINC: 92766-8 ICD-10: Q87.8 Clinical summary This genetic test identifies pathogenic variants within the BBS10 gene, which are associated with Bardet-Biedl syndrome type 10.
TEST-3951 BBS2 Gene Bardet‑Biedl Syndrome Type 2 Genetic Test This test evaluates the BBS2 gene for pathogenic variants associated with Bardet-Biedl syndrome type 2.	Whole Blood, Extracted DNA, FTA Card (one drop)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BBS2 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations (CNVs)"] Parameters [] Preparation ["Complete a detailed clinical history form", "Mandatory pre-test genetic counselling", "No dietary restrictions", "Continue usual medications unless advised otherwise", "Avoid anticoagulants if whole blood is required (consult doctor)", "An FTA card may be substituted for whole blood"] Indications ["Individuals with clinical features suggestive of Bardet-Biedl syndrome type 2", "Family members of affected patients seeking carrier or presymptomatic diagnosis after genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.8 Clinical summary This test evaluates the BBS2 gene for pathogenic variants associated with Bardet-Biedl syndrome type 2.
TEST-3947 BBS4 Gene Bardet-Biedl Syndrome Type 4 Genetic Test This test identifies pathogenic variants in the BBS4 gene, confirming Bardet-Biedl syndrome type 4.	Whole Blood or Buccal Swab	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BBS4 gene", "Copy Number Variations (CNV) in BBS4"] Parameters [] Preparation ["No fasting required"] Indications ["Family history of Bardet-Biedl syndrome type 4", "Clinical features suggestive of Bardet-Biedl syndrome type 4"] Measurement technique Confirm with laboratory Codes LOINC: 92810-9 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the BBS4 gene, confirming Bardet-Biedl syndrome type 4.
TEST-3894 BBS7 Gene Bardet-Biedl Syndrome Type 7 Genetic Test This genetic test analyzes the BBS7 gene for mutations associated with Bardet-Biedl Syndrome Type 7.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Insertions", "Deletions", "Copy number variations (CNVs) in the BBS7 gene"] Parameters [] Preparation ["No fasting required", "No special preparation required"] Indications ["Suspected Bardet-Biedl Syndrome Type 7", "Family history of BBS7", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 82319-9 ICD-10: Q87.8 Clinical summary This genetic test analyzes the BBS7 gene for mutations associated with Bardet-Biedl Syndrome Type 7.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories